GSK Investigational Site

Cipolletti, Río Negro Province R8324EMB

0 studies enrolling now · 5 studies all time

What they study most

Lung Cancer, Non-Small Cell, Melanoma, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor — Stopped early
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study — Completed